Article Text

other Versions

PDF
Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalities
  1. Paul D Morris1,
  2. Tim Robinson2,
  3. Kevin S Channer3
  1. 1Department of Cardiology, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
  2. 2Department of Cardiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
  3. 3Department of Cardiology, Royal Hallamshire Hospital, Sheffield, UK
  1. Correspondence to Dr Paul Morris, Cardiology, Sheffield Teaching Hospitals NHS Trust, Herries Road, Sheffield S5 7AU, UK; paulmorris{at}doctors.org.uk

Abstract

Heart failure is usually a relentless condition associated with a poor prognosis. Triggered by a physiological insult, maladaptive neurohumoral processes result in an ever-spiralling deterioration of cardiovascular function. However, there are certain underlying conditions which are associated with a temporary reduction in contractile function leading to reversible heart failure. These conditions affect a relatively small number of patients when compared with heart failure secondary to inherited cardiomyopathies and ischaemic heart disease. There are two broad mechanisms responsible for reversible myocyte dysfunction: acute inflammatory activation in which cytokines depress myocyte function, and toxic effects in which there is impairment of intra-cellular energetics. In this review, we discuss reversible heart failure caused by toxic effects. These effects can be caused by drugs (prescribed and illicit) and by tachycardic arrhythmia (tachycardiomyopathy), and are caused by abnormalities of mitochondrial function and myocytic calcium processing. The underlying pathological mechanisms, clinical features and management options are discussed, illustrated by clinical case studies.

  • Adult cardiology
  • cardiomyopathy
  • heart failure
  • pacing and electrophysiology
  • echocardiography
  • valvular heart disease
  • myocardial infarction
  • coronary heart disease

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.